Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Francis Murphy

Dermatology New Windsor, NY Medical Doctor

NPI 1437254810 CMS profile 20356

819 Little Britain Road Suite 100, New Windsor, NY 12553

Open in the dashboard

General payments

$4,732

244 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Francis Murphy of New Windsor, NY is reported in the CMS Open Payments database as having received $4,732 across 244 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $520 21
2024 General $793 30
2023 General $986 48
2022 General $941 52
2021 General $946 61
2020 General $518 30
2019 General $29 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Francis Murphy
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Francis Murphy were reported at $520. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Francis Murphy Dermatology median Middle half National median
2019 $29 $454 $129–$1,240 $163
2020 $518 $235 $81–$756 $114
2021 $946 $377 $108–$1,108 $132
2022 $941 $514 $143–$1,391 $149
2023 $986 $607 $159–$1,674 $160
2024 $793 $751 $204–$1,903 $164
2025 $520 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,235 84 payments
  2. LEO Pharma Inc. $449 25 payments
  3. Incyte Corporation $411 15 payments
  4. Amgen Inc. $378 17 payments
  5. E.R. Squibb & Sons, L.L.C. $338 11 payments
  6. UCB, Inc. $329 14 payments
  7. Lilly USA, LLC $306 14 payments
  8. Novartis Pharmaceuticals Corporation $275 15 payments
  9. Janssen Biotech, Inc. $191 10 payments
  10. Genzyme Corporation $182 9 payments
  11. Other $637 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,732 244 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI $783 57 payments
  2. HUMIRA $633 39 payments
  3. OPZELURA $411 15 payments
  4. Otezla $378 17 payments
  5. SOTYKTU $338 11 payments
  6. DUPIXENT $246 12 payments
  7. ENSTILAR $239 15 payments
  8. Cimzia $215 10 payments
  9. ADBRY $209 10 payments
  10. TALTZ $194 10 payments
  11. Other $1,887 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

712

Median for Dermatology: 534

Drug cost

$99,978

Median for Dermatology: $67,151

Branded share of claims

4.9%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sotyktu Deucravacitinib Brand 12 $77,153
Betamethasone Dipropionate Generic 103 $5,319
Ketoconazole Generic 172 $3,456
Clobetasol Propionate Generic 79 $3,382
Fluorouracil Generic 30 $1,935
Metronidazole Generic 43 $1,862
Tacrolimus Generic 12 $1,426
Clindamycin Phosphate Generic 32 $1,296
Hydrocortisone Generic 62 $960
Nystatin Generic 27 $813

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$163,039

Of which drugs: $18

Medicare patients

632

Average age 75

Services billed

2,646

352 women, 280 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 44%
Ischemic heart disease 32%
Diabetes 28%
Osteoporosis 16%
Atrial fibrillation 15%
COPD 15%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 19 25 $18

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 15 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $338
$338 12 —
Otezla
  • Amgen Inc. $62
$62 — —
OLUMIANT
  • Lilly USA, LLC $59
$59 — —
OPZELURA
  • Incyte Corporation $51
$51 — —
CYLTEZO
  • Boehringer Ingelheim Pharmaceuticals, Inc. $46
$46 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 15 in the dashboard with a free account

Records

244 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record